Invention Grant
- Patent Title: Selective histone deacetylase inhibitors for the treatment of human disease
-
Application No.: US16476006Application Date: 2018-01-09
-
Publication No.: US11034667B2Publication Date: 2021-06-15
- Inventor: Scott Grindrod , Mira Jung , Milton Brown , Anatoly Dritschilo
- Applicant: Shuttle Pharmaceuticals, Inc.
- Applicant Address: US MD Rockville
- Assignee: Shuttle Pharmaceuticals, Inc.
- Current Assignee: Shuttle Pharmaceuticals, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Morgan, Lewis & Bockius, LLP
- International Application: PCT/US2018/012971 WO 20180109
- International Announcement: WO2018/129533 WO 20180712
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D211/88 ; A61P35/00 ; A61K45/06
Abstract:
Selective HDAC inhibitors, and pharmaceutical compositions that include the same, are described herein for the treatment of cancer, immunological diseases, inflammatory diseases, and neurological diseases.
Public/Granted literature
- US20200071288A1 SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASE Public/Granted day:2020-03-05
Information query
